Preview: Iridex's Earnings
Iridex (NASDAQ:IRIX) releases its next round of earnings this Monday, March 22. Here is Benzinga's essential guide to Iridex's Q4 earnings report.
Net Income, Earnings, And Earnings Per Share
Earnings and EPS are useful metrics of profitability. Total earnings also known as net income is equal to total revenue minus total expenses. Dividing net income by the total number of shares outstanding yields EPS.
Earnings And Revenue
Wall Street analysts see Iridex reporting a loss of $0.1 per share on revenue of $12.26 million. In the same quarter last year, Iridex reported a loss per share of $0.11 on revenue of $11.76 million.
What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter?
Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin.
The analyst consensus estimate would represent a 9.09% increase in the company's earnings. Sales would be have grown 4.23% from the same quarter last year. Here is how the company's reported EPS has stacked up against analyst estimates in the past:
EPS Estimate | -0.17 | -0.22 | -0.16 | -0.15 |
EPS Actual | -0.12 | -0.20 | -0.12 | -0.11 |
Revenue Estimate | 7.79 M | 5.94 M | 9.76 M | 10.88 M |
Revenue Actual | 8.80 M | 6.22 M | 9.02 M | 11.76 M |
Stock Performance
Over the last 52-week period, shares are up 421.43%. Given that these returns are generally positive, long-term shareholders can relax going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.
Do not be surprised to see the stock move on comments made during its conference call. Iridex is scheduled to hold the call at 17:00:00 ET and can be accessed here.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
